TGen IDs targets for nonalcoholic fatty liver disease

Researchers at the Translational Genomics Research Institute (TGen) say they have identified a potential gene associated with the initiation of nonalcoholic fatty liver disease, the most common cause of liver damage. Among the potential gene targets, they found that miR-182 produced a strong association with a protein called FOX03. Release

Suggested Articles

German scientists are targeting a protein-cutting enzyme that many viruses, including the coronavirus COVID-19, need to replicate.

UPenn scientists found blocking the Wnt/beta-catenin pathway in endothelial cells made chemotherapy more effective in mouse models of glioblastoma.

Astellas’ Xospata and Novartis’ Rydapt may help treat lung cancer that has grown resistant to EGFR inhibitors, researchers discovered.